BeOne Medicines Ltd (6160) Gets a Buy from Daiwa
Daiwa analyst maintained a Buy rating on BeOne Medicines Ltd on November 9 and set a price target of HK$286.00.
Currently, the analyst consensus on BeOne Medicines Ltd is a Strong Buy with an average price target of HK$344.56.
